Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies

European Journal of Cardio-thoracic Surgery

Volumn 36, Issue 4, 2009, Pages 759-763

  Trousse, Delphine Sophie ^a,b   Avaro, Jean Philippe ^a,b   D'Journo, Xavier Benoit ^a,b   Doddoli, Christophe ^a,b   Astoul, Philippe ^a,b   Giudicelli, Roger ^a,b   Fuentes, Pierre A ^a,b   Thomas, Pascal Alexandre ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Extra pleural pneumonectomy; Malignant pleural mesothelioma; Overall survival; Prognostic factors

Indexed keywords

CISPLATIN; PEMETREXED;

ADULT; AGED; ARTICLE; BRONCHOPLEURAL FISTULA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; EMPYEMA; FEMALE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; MORBIDITY; MORTALITY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURA; PLEURAL NEOPLASMS; PNEUMONECTOMY; PROGNOSIS; TREATMENT OUTCOME;

EID: 69849113465     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.04.044     Document Type: Article

References (25)

1. Rusch V.W. A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer 14 (1996) 1-12
2. Staging system proposed by UICC. Handbook for staging of Cancer, 4th ed. Philadelphia: J.B. Lippincott,1993;137-8.
3. Maziak D.E., Gagliari A., Haynes A.E., Mackay J.A., and Evans W.K. Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary. Lung Cancer 48 (2005) 157-169
4. Butchart E.G., Ashcroft T., Barnsley W.C., and Holden M.P. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 31 (1976) 15-24
5. Schipper P.H., Nichols F.C., Thomse K.M., Deschamps C., Cassivi S.D., Allen M.S., and Pairolero P.C. Malignant pleural mesothelioma: surgical management in 285 patients. Ann Thorac Surg 85 (2008) 257-354
6. Aigner C., Hoda M.A., Lang G., Taghavi S., Marta G., and Klepetko W. Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Thorac Cardiovasc Surg 34 (2008) 204-207
7. Batirel H.F., Metintas M., Caglar H.B., Yildizeli B., Lacin T., Bostanci K., Akgul A.G., Evman S., and Yuksel M. Trimodality treatment of malignant pleural mesothelioma. J Thorac Oncol 3 (2008) 499-504
8. Okada M., Mimura T., Ohbayashi C., Sakuma T., Soejima T., and Tsubota N. Radical surgery for malignant pleural mesothelioma: results and prognosis. Interact Cardiovasc Thorac Surg 7 (2008) 102-106
9. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., Richards W.G., Strauss G.M., Corson J.M., DeCamp M.M., Swanson S.J., Bueno R., Lukanich J.M., Baldini A.H., and Mentzer S.J. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117 (1999) 54-63
10. Riquet M., Bagan P., Le Pimpec Barthes F., Banu E., Scotte F., Foucault C., Dujon A., and Danel C. Completely resected non-small cell lung cancer: reconsidering prognostic value and significance of N2 metastases. Ann Thorac Surg 84 (2007) 1818-1824
11. Robinson L.A., Ruckdeschel J.C., Wagner H., and Stevens C.W. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines(2nd edition). Chest 132 3 Suppl. (2007) 234S-265S
12. Martin-Ucar A.E., Edwards J.G., Rengajaran A., Muller S., and Waller D.A. Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. Eur J Cardiothorac Surg 20 (2001) 1117-1121
13. Martin-Ucar A.E., Nakas A., Edwards J.G., and Waller D.A. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma. Eur J Cardiothorac Surg 31 (2007) 765-770
14. Nakas A., Trousse D.S., Martin-Ucar A.E., and Waller D.A. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy. Eur J Cardiothorac Surg 34 (2008) 886-891
15. Flores R.M., Pass H.I., Venkatraman E.S., Dycoco J., Zakowski M., Carbone M., Bains M.S., and Rusch V.W. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac CardioVasc Surg 135 (2008) 620-626
16. Pass H.I., Temeck B.K., Kranda K., and Steinberg S. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Lung Cancer 15 (1996) 277
17. Rusch V.W. Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 9 (1997) 367-372
18. Flores R.M., Krug L.M., Rosenweig K.E., Venkatraman E., Vincent A., Heelan R., Akhurst T., and Rusch V.W. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol 1 (2006) 289-295
19. Sugarbaker D.J., Jaklitsch M.T., Bueno R., Richards W., Lukanich J., Mentser S.J., Colson Y., Linden P., Chang M., Capalbo L., Oldread E., Neragi-miandoab S., Swanson S.J., and Zellos L.S. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 128 (2004) 138-146
20. Sugarbaker D.J., Mentzer S.J., and Strauss G. Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. Ann Thorac Surg 54 (1992) 941-946
21. Stewart D.J., Martin-Ucar A.E., Edwards J.G., Weest K., and Waller D.A. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations. Eur J Cardiothorac Surg 27 (2005) 373-378
22. De perrot M., Mcrae K., Anraku M., Karkouti K., Waddell T.K., Pierre A.F., Darling G., Keshavjee S., and Johnston M.R. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma. Ann Thorac Surg 85 (2008) 1206-1210
23. Rusch V.W., and Venkatraman E.S. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 68 (1999) 1799-1804
24. Soysal O., Karaoglanoglu N., Demiracan S., Topcu S., tatstepe I., Kaya S., Unlu M., and Cetin G. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur J Cardiothorac Surg 11 (1997) 210-213
25. Halstead J.C., Lim E., Venkateswaran R.M., Charman S.C., Goddard M., and Ritchie A.J. Improved survival with VATS pleurectomy/decortication in advanced malignant mesothelioma. Eur J Surg Oncol 31 (2005) 314-320